masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.
Company profile
Ticker
MASI
Exchange
Website
CEO
Joseph Kiani
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical • Fonar ...
SEC CIK
Corporate docs
Subsidiaries
Masimo Americas, Inc. • Masimo de Mexico Holdings I LLC • Masimo de Mexico Holdings II LLC • Masimo Holdings LLC • SpO2.com, Inc. • SEDLine, Inc. • Masimo Australia Pty Ltd • Masimo Öesterreich GmbH • Masimo Importacao e Distribuicao de Produtos Medicos Ltda • Masimo Holdings LP ...
IRS number
330368882
MASI stock data
Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
1 Apr 24
DEFA14A
Additional proxy soliciting materials
1 Apr 24
DFAN14A
Additional proxy materials by non-management
25 Mar 24
8-K
Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
22 Mar 24
10-K
2023 FY
Annual report
28 Feb 24
8-K
Masimo Reports Fourth Quarter and Full-Year 2023 Financial Results
27 Feb 24
8-K
Departure of Directors or Certain Officers
15 Feb 24
8-K
Masimo Announces New Member of the Board of Directors
16 Jan 24
8-K
Masimo Announces Select Preliminary 2023 Financial Results and 2024 Guidance
10 Jan 24
8-K
Other Events
22 Nov 23
Transcripts
MASI
Earnings call transcript
2023 Q4
27 Feb 24
MASI
Earnings call transcript
2023 Q3
7 Nov 23
MASI
Earnings call transcript
2023 Q2
8 Aug 23
MASI
Earnings call transcript
2023 Q1
9 May 23
MASI
Earnings call transcript
2022 Q4
28 Feb 23
MASI
Earnings call transcript
2022 Q3
9 Nov 22
MASI
Earnings call transcript
2022 Q2
10 Aug 22
MASI
Earnings call transcript
2022 Q1
3 May 22
MASI
Earnings call transcript
2021 Q4
16 Feb 22
MASI
Earnings call transcript
2021 Q3
27 Oct 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jul 23 | Apr 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Jan 22 | Jan 21 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 132.30 mm | 132.30 mm | 132.30 mm | 132.30 mm | 132.30 mm | 132.30 mm |
Cash burn (monthly) | 8.77 mm | 7.48 mm | (no burn) | (no burn) | 2.33 mm | (no burn) |
Cash used (since last report) | 58.39 mm | 49.84 mm | n/a | n/a | 15.54 mm | n/a |
Cash remaining | 73.91 mm | 82.46 mm | n/a | n/a | 116.76 mm | n/a |
Runway (months of cash) | 8.4 | 11.0 | n/a | n/a | 50.0 | n/a |
Institutional ownership, Q3 2023
89.8% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 349 |
Opened positions | 63 |
Closed positions | 115 |
Increased positions | 79 |
Reduced positions | 154 |
13F shares | Current |
---|---|
Total value | 4.16 tn |
Total shares | 47.52 mm |
Total puts | 546.90 k |
Total calls | 2.24 mm |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 5.41 mm | $474.55 bn |
FMR | 5.25 mm | $460.11 bn |
Vanguard | 4.75 mm | $416.91 bn |
Politan Capital Management | 4.71 mm | $413.28 bn |
Capital Research Global Investors | 2.13 mm | $186.98 bn |
Massachusetts Financial Services | 1.51 mm | $132.70 bn |
RTW Investments | 1.50 mm | $131.65 bn |
STT State Street | 1.40 mm | $123.03 bn |
Eminence Capital | 1.04 mm | $90.86 bn |
T. Rowe Price Investment Management | 917.53 k | $80.77 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | Blair Tripodi | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
1 Mar 24 | Blair Tripodi | NQSO Common Stock | Grant | Acquire A | No | No | 126.49 | 9,127 | 1.15 mm | 9,127 |
1 Mar 24 | McClenahan Thomas Samuel | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
1 Mar 24 | McClenahan Thomas Samuel | NQSO Common Stock | Grant | Acquire A | No | No | 126.49 | 11,954 | 1.51 mm | 11,954 |
1 Mar 24 | Muhsin Bilal | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
1 Mar 24 | Muhsin Bilal | NQSO Common Stock | Grant | Acquire A | No | No | 126.49 | 11,954 | 1.51 mm | 11,954 |
1 Mar 24 | Levy Tao | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
1 Mar 24 | Levy Tao | NQSO Common Stock | Grant | Acquire A | No | No | 126.49 | 7,390 | 934.76 k | 7,390 |
1 Mar 24 | Young Micah W | RSU Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
1 Mar 24 | Young Micah W | NQSO Common Stock | Grant | Acquire A | No | No | 126.49 | 11,954 | 1.51 mm | 11,954 |
News
Forecasting The Future: 6 Analyst Projections For Masimo
15 Apr 24
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
15 Apr 24
Stifel Upgrades Masimo to Buy, Raises Price Target to $170
15 Apr 24
Tim Cook-Led Tech Giant Appeals To US Court For Overturning Import Ban On Its Apple Watches
6 Apr 24
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
25 Mar 24
Press releases
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
16 Apr 24
Masimo Responds to Politan Capital's Nomination of Director Candidates and Refutes Politan's False Claims
1 Apr 24
Politan Nominates Two Independent Candidates for Masimo Board
25 Mar 24
Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
22 Mar 24
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
21 Mar 24